The Estée Lauder Companies, Inc.

  • Market Cap: Mid Cap
  • Industry: FMCG
  • ISIN: US5184391044
USD
103.82
1.79 (1.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About The Estée Lauder Companies, Inc. stock-summary
stock-summary
The Estée Lauder Companies, Inc.
FMCG
The Estee Lauder Companies Inc. manufactures and markets skin care, makeup, fragrance and hair care products. The Company offers products, including skin care, makeup, fragrance, hair care and other. The Company operates in beauty products segment. The Company's products are sold in over 150 countries and territories under brand names, including Estee Lauder, Aramis, Clinique, Prescriptives, Lab Series, Origins, Tommy Hilfiger, MAC, Kiton, La Mer, Bobbi Brown, Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble, Michael Kors, Darphin, Tom Ford, Smashbox, Ermenegildo Zegna, AERIN, Tory Burch, RODIN olio lusso, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, By Kilian, BECCA and Too Faced. Its skin care products include moisturizers, serums, cleansers, toners, body care, exfoliators, acne and oil correctors, facial masks, cleansing devices and sun care products.
Company Coordinates stock-summary
Company Details
767 5th Ave , NEW YORK NY : 10153-0023
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 174 Schemes (47.18%)

Foreign Institutions

Held by 557 Foreign Institutions (36.6%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. William Lauder
Executive Chairman of the Board
Mr. Leonard Lauder
Chairman Emeritus
Mr. Fabrizio Freda
President, Chief Executive Officer, Director
Ms. Sara Moss
Vice Chairman of the Board
Mr. Ronald Lauder
Chairman of Clinique Laboratories, LLC, Director
Mr. Richard Parsons
Director
Amb. Charlene Barshefsky
Independent Director
Ms. Rose Bravo
Independent Director
Ms. Wei Christianson
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3,407 Million
(Quarterly Results - Jun 2025)
Net Profit:
-546 Million
stock-summary
Industry

FMCG

stock-summary
Market cap

USD 53,151 Million (Mid Cap)

stock-summary
P/E

40.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

47.42%

stock-summary
Debt Equity

1.24

stock-summary
Return on Equity

20.29%

stock-summary
Price to Book

13.75